ThirdWave Molecular Diagnostics

“We became, overnight, a much more solid and substantial enterprise due to the investment.”
-Lloyd Smith,
 ThirdWave Molecular Diagnostics, Co-Founder

The Opportunity

Third Wave Molecular Diagnostics is a diagnostics company that created tests for HPV virus, a sexually transmitted infection that can cause cervical cancer.

How We Helped

Venture Investors provided seed financing to the first company in which the Wisconsin Alumni Research Foundation accepted equity in lieu of an upfront management fee. We served as lead investor, building a strong syndicate through multiple rounds and an IPO. John Neis served on the Board from seed stage through IPO


Third Wave was acquired by Hologic for $580 million.